Sympathetic Signaling
The Sympathetic Nervous System
Sympathetic Pathways: Collateral Ganglia and Adrenal Medulla
Sympathetic Division of the ANS
Sympathetic Activation
Gross Anatomy of the Lungs
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 8, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Tala Fnu1,2, Peiguo Shi3,4, Wanwei Zhang5
1Department of Medicine, Columbia Center for Human Development, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, New York.
Targeting sympathetic nerves or the ADRB2 receptor slows small cell lung cancer (SCLC) progression. Inhibiting ADRB2 disrupts PKA signaling, offering a new therapeutic strategy for aggressive SCLC.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: